Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report

Juan Ignacio Muñoz-Bonet1,2, Francisco José Sebastián-Cuevas1, Eva María Flor-Macián1

  • 1Paediatric Intensive Care Unit Hospital Clínico Universitario Valencia Spain.

PubMed

Insights

Malignant pertussis (MP) in infants can cause severe pulmonary hypertension (PHT). Controlling hypercapnia, a buildup of carbon dioxide, improved PHT in a severe case, suggesting a modifiable factor in MP management.

Area of Science:

  • Pediatrics
  • Intensive Care Medicine
  • Pulmonology

Background:

  • Malignant pertussis (MP) is a severe complication in infants, often leading to hyperleukocytosis, pulmonary hypertension (PHT), and multiorgan failure.
  • Pulmonary vascular damage is often cited as the cause of irreversible PHT and poor prognosis in MP.
  • This case challenges that notion by demonstrating PHT improvement with CO2 management.

Purpose of the Study:

  • To present a case of malignant pertussis with severe pulmonary hypertension.
  • To investigate the role of hypercapnia in exacerbating PHT during MP.
  • To highlight a potentially modifiable pathophysiological mechanism in MP management.

Main Methods:

  • Case report of a 44-day-old infant with pertussis, hypoxemia, and acute respiratory distress syndrome.
  • Monitoring and management of PHT and hypercapnia.
  • Utilized high-frequency oscillatory ventilation for precise carbon dioxide control.

Main Results:

  • The infant developed severe PHT, which worsened with permissive hypercapnia.
  • Effective carbon dioxide control using high-frequency oscillatory ventilation led to sustained clinical improvement.
  • This suggests PHT in MP may be, in part, a reversible consequence of hypercapnia.

Conclusions:

  • Sustained control of hypercapnia can improve pulmonary hypertension in malignant pertussis.
  • This offers a novel, potentially modifiable therapeutic target for managing MP.
  • Further research is warranted to explore CO2 management strategies in MP.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.7K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
738